349438 <common-name>(2s,3s,4s,5r)-6-[2-[2-(4-chlorophenyl)-1-(4-hydroxyphenyl)-6,6-dimethyl-5,7-dihydropyrrolizin-3-yl]acetyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid</common-name> <description>(2s,3s,4s,5r)-6-[2-[2-(4-chlorophenyl)-1-(4-hydroxyphenyl)-6,6-dimethyl-5,7-dihydropyrrolizin-3-yl]acetyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid is a chemical compound with the formula C29H30ClNO9. With an average molecular weight of 572.00 g/mol, (2s,3s,4s,5r)-6-[2-[2-(4-chlorophenyl)-1-(4-hydroxyphenyl)-6,6-dimethyl-5,7-dihydropyrrolizin-3-yl]acetyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>154699777</pubchem-id> <chemical-formula>C29H30ClNO9</chemical-formula> <weight>572</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T14:02:34Z</created-at> <updated-at type="dateTime">2026-08-31T14:02:34Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1(CC2=C(C(=C(N2C1)CC(=O)OC3C(C(C(C(O3)C(=O)O)O)O)O)C4=CC=C(C=C4)Cl)C5=CC=C(C=C5)O)C</moldb-smiles> <moldb-formula>C29H30ClNO9</moldb-formula> <moldb-inchi>InChI=1S/C29H30ClNO9/c1-29(2)12-19-22(15-5-9-17(32)10-6-15)21(14-3-7-16(30)8-4-14)18(31(19)13-29)11-20(33)39-28-25(36)23(34)24(35)26(40-28)27(37)38/h3-10,23-26,28,32,34-36H,11-13H2,1-2H3,(H,37,38)/t23-,24-,25+,26-,28?/m0/s1</moldb-inchi> <moldb-inchikey>LXLRVOZCAXHOTL-TXZJZKILSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">571.1609092</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>3.3</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM345331</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(2s,3s,4s,5r)-6-[2-[2-(4-chlorophenyl)-1-(4-hydroxyphenyl)-6,6-dimethyl-5,7-dihydropyrrolizin-3-yl]acetyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom nil="true"/> <superklass nil="true"/> <klass nil="true"/> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0299762</sync-id> <structure-inchikey>LXLRVOZCAXHOTL-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>840000000000000000100000000001000080000000000000000000000002040000100000000004000000000000000000000000400000000000020000400000000020000080004020800000000300000000010040000000000000010082000000000000000000800000020118000080000400000000100004000048020000000000004200000000800400000000000000000000400020000000004010000000000000082000000002010000000000000100800000000000000000000000002000000000000000008010000000000000001200000020000000000000000000000040000000000440000000000000080000000002000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAoAAAALAAAAIABBgBgAAAAAQMGACAAAAAE BgBgAAAAAgIGQCgAAAADBAZAKAAAAAMEBkAoAAAAAwQGQCgAAAADBAdAKAAA AAMDBgBgAAAAAgIGAGAAAAACAgYAKAAAAAMECAAoAAAAAwIIACgAAAADAgYA YAAAAAMBBgBgAAAAAwEGAGAAAAADAQYAYAAAAAMBBgBgAAAAAwEIACAAAAAC BgAoAAAAAwQIACgAAAADAggAaAAAAAMBAQgAYAAAAAEBCABgAAAAAQEIAGAA AAABAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAAD AwEGQGgAAAADAwERACAAAAABBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEG QCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQgAaAAAAAMBAQYAYAAAAAEDCwAB AAECAAIDAAMEaAwEBWgMBQZoDAYHaAwHCAAGCQAJCgAKCygCCgwgDA0ADQ4A Dg8ADxAAEBEAERIAERMAExQoAhMVIBAWAA8XAA4YAAUZIBkaaAwaG2gMGxxo DBwdaAwdHmgMHB8ABCAgICFoDCEiaAwiI2gMIyRoDCQlaAwjJiABJwAIAQAH A2gMEg0AHhloDCUgaAxCBQAAAAUBAgMHCAYODxAREg0GGhscHR4ZBiEiIyQl IAUDBAUGBxcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:47:33Z</structure-indexed-at> </compound>